The first long-term record of how cancer patients made use of their stored eggs and embryos after cancer treatment is presented today at the 36th Annual Meeting of ESHRE. The results demonstrate from the 20-year data how successful fertility preservation can be in these patients, especially those with breast cancer. Details of the analysis, covering the longest reported period of use, are presented today online by Dr Dalia Khalife at the virtual Annual Meeting of ESHRE.
The prospect of a non-invasive test of ovarian reserve is a little closer following results from a study showing that measurement of a fertility hormone can be accurately taken from a sample of human hair.
Motile sperm are difficult to collect with a conventional cell sorter because they are vulnerable to physical damage. A Japanese research collaboration has developed a technique using a cell sorter with microfluidic chip technology to reduce cell damage and improve in vitro fertilization rates. This research is expected to increase in vitro fertilization rates to improve production of experimental animals and livestock, and could be used as a fertility treatment in reproductive medicine.
'Be fruitful and multiply' says the Bible, and worldwide religious people tend to have more children than their secular counterparts. New research suggests that this 'multiplying' may be the result of the higher levels of support from non-family members that church-going women receive, and that these greater levels of support are also associated with positive developmental outcomes for children.
Australian researchers have shown for the first time that a new drug used to treat breast cancer patients damages the store of immature eggs in the ovaries of mice. Authors of the study published in Human Reproduction journal say fertility counselling should be considered for young women who may be about to be treated with olaparib.
Yale Cancer Center (YCC) scientists have found that combining the targeted drug trastuzumab with chemotherapy significantly improves survival rates for women with a rare, aggressive form of endometrial cancer. These results may help to change the standard of care worldwide for the disease. The findings are published today in the journal Clinical Cancer Research.
WFIRM scientists were able to show that bioengineered uteri in an animal model developed the native tissue-like structures needed to support normal reproductive function.
Women with premature ovarian insufficiency (POI) become estrogen deficient at an early age, which makes them more vulnerable to the loss of bone mineral density. A new study suggests that use of continuous combined oral contraceptives may be especially effective in reducing bone mass loss. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS).
UC Davis Health researchers took a critical step in defining the possible paths for SARS-CoV-2 causing COVID-19 to get transmitted from the mother to her newborn baby.
Polycystic ovary syndrome (PCOS), an infertility disorder affecting at least 15% of reproductive-age women, may have at least two different subtypes, suggests a study funded by the National Institutes of Health. The findings could provide important information on the possible causes of PCOS and for developing more effective ways to treat the condition.